Fosun is not a state-owned enterprise, but an investment group.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (Fosun Pharmaceutical) was founded in 1994, is China's leading, innovation-driven, international pharmaceutical and health industry group, the business field of strategic layout of the pharmaceutical and health industry chain, the direct operation of the business includes pharmaceuticals, medical devices and medical diagnostics, medical services, and through the shareholding of Sinopharm Holdings covers the pharmaceuticals, medical devices and medical diagnostics, and medical services. Its direct operations include pharmaceuticals, medical devices, medical diagnostics, and medical services, and through its participation in Sinopharm Holdings, it covers the pharmaceutical business sector.
Facing the future, Fosun Pharma will be guided by the strategy of "4IN" (Innovation, Internationalization, Integration and Intelligentization), and adhering to the principle of "Innovation and Transformation, Integration and Operation". Under the guidance of the "4IN" strategy, we are committed to becoming a first-class enterprise in the global mainstream healthcare market by adhering to the development model of "Innovation and Transformation, Integration and Operation, and Steady Growth" as well as the concept of sustainable development.
Social Responsibility
Fosun Pharma has always regarded sustainable development as an important indicator of corporate operation, and has been actively undertaking corporate social responsibility by adhering to the social responsibility concept of "pursuing sustainable development of talents and products".
Fosun Pharma continues to carry out various public welfare activities in the areas of health and poverty alleviation, support for education, scientific research and innovation, and care for children, etc. In FY2020, Fosun Pharma donated 40.38 million yuan to the society.
During the epidemic, Fosun Pharma made emergency deployment and worked overtime to guarantee the first-line supply of important medical materials. It has donated many batches of protective clothing, masks and other medical supplies to the front line of the epidemic areas such as Wuhan and Huanggang in Hubei province, supporting the national medical team, Wuhan Union Medical College Hospital, Leishenshan Hospital and other medical institutions.
By the end of 2020, Fosun Pharma had donated cash and medical equipment and living materials such as medical masks, protective clothing, medical non-invasive ventilators, negative pressure ambulances and other medical equipment and living materials with a cumulative value of more than 30 million yuan to the infected areas.